Literature DB >> 305255

The T and B lymphocyte content of lymph nodes and spleen in Hodgkin's disease.

G Stathopoulos, M Papamichail, M J Peckham, A J Davies, E J Holborow.   

Abstract

Lymphocytes from tumour-bearing lymph nodes in 15 patients with Hodgkin's disease, and lymphocytes from 6 spleens infiltrated by Hodgkin's tissue and 6 tumour-free spleens were studied using T and B lymphocyte markers. For comparison, lymphocytes from 16 tumour-free lymph nodes were similarly assessed. It was found that the tumour-bearing nodes showed a predominance of T lymphocytes compared with the control nodes, whereas in involved splenic tissue the proportion of T lymphocytes was slightly reduced compared with uninvolved spleens.

Entities:  

Mesh:

Year:  1977        PMID: 305255      PMCID: PMC2041294     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  25 in total

1.  Nodular lymphoma--evidence for origin from follicular B lymphocytes.

Authors:  E S Jaffe; E M Shevach; M M Frank; C W Berard; I Green
Journal:  N Engl J Med       Date:  1974-04-11       Impact factor: 91.245

2.  The mitogenic response of human B lymphocytes to phytohaemagglutinin.

Authors:  B Phillips; E Weisrose
Journal:  Clin Exp Immunol       Date:  1974-03       Impact factor: 4.330

3.  Formation of mouse or sheep red-blood-cell rosettes by lymphocytes from normal and leukaemic individuals.

Authors:  G Stathopoulos; E V Elliott
Journal:  Lancet       Date:  1974-04-06       Impact factor: 79.321

4.  Immunoglobulins on the surface of human lymphocytes.

Authors:  M Papamichail; J C Brown; E J Holborow
Journal:  Lancet       Date:  1971-10-16       Impact factor: 79.321

5.  Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).

Authors:  J Libánský; M Lukásová; I Pinosová
Journal:  Neoplasma       Date:  1973       Impact factor: 2.575

6.  Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients.

Authors:  R C Young; M P Corder; H A Haynes; V T DeVita
Journal:  Am J Med       Date:  1972-01       Impact factor: 4.965

7.  Letter: T and B lymphocytes in spleen in Hodgkin's disease.

Authors:  R R Joseph; D Belpomme
Journal:  Lancet       Date:  1975-03-29       Impact factor: 79.321

8.  Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.

Authors:  J C Brouet; S Labaume; M Seligmann
Journal:  Br J Cancer Suppl       Date:  1975-03

9.  T and B cell populations in blood and lymph node in lymphoproliferative disease.

Authors:  D A Cooper; V Petts; E Luckhurst; J C Biggs; R Penny
Journal:  Br J Cancer       Date:  1975-05       Impact factor: 7.640

10.  The thymic origin of Hodgkin's disease.

Authors:  A D THOMSON
Journal:  Br J Cancer       Date:  1955-03       Impact factor: 7.640

View more
  3 in total

1.  Acid alpha-naphthyl acetate esterase activity in human neoplastic lymphoid cells. Usefulness as a T-cell marker.

Authors:  D M Knowles; J P Halper; G A Machin; W Sherman
Journal:  Am J Pathol       Date:  1979-07       Impact factor: 4.307

Review 2.  Therapeutic implications of menin inhibition in acute leukemias.

Authors:  Ghayas C Issa; Farhad Ravandi; Courtney D DiNardo; Elias Jabbour; Hagop M Kantarjian; Michael Andreeff
Journal:  Leukemia       Date:  2021-06-15       Impact factor: 11.528

Review 3.  Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence.

Authors:  Alexandre Teixeira Vessoni; Eduardo Cremonese Filippi-Chiela; Guido Lenz; Luis Francisco Zirnberger Batista
Journal:  Oncogene       Date:  2019-12-04       Impact factor: 9.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.